Point72 Europe’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.53M | Buy |
33,824
+18,774
| +125% | +$1.96M | 0.14% | 109 |
|
|
2025
Q1 | $1.76M | Sell |
15,050
-26,684
| -64% | -$3.11M | 0.12% | 112 |
|
|
2024
Q4 | $3.53M | Buy |
41,734
+7,164
| +21% | +$606K | 0.2% | 93 |
|
|
2024
Q3 | $3.11M | Buy |
34,570
+3,829
| +12% | +$344K | 0.2% | 88 |
|
|
2024
Q2 | $2.47M | Buy |
+30,741
| New | +$2.47M | 0.2% | 105 |
|